Status:
COMPLETED
Study of the Impact of an Intervention Performed by a Clinical Pharmacist on Patients at Risk of Pneumococcal Infection at the End of Hospitalization
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Vaccination
Eligibility:
All Genders
18+ years
Brief Summary
In France, Streptococcus pneumoniae is the leading agent involved in community-acquired bacterial pneumopathies and bacterial meningitis. The frequency of these infections is increasing in at-risk sub...
Eligibility Criteria
Inclusion
- Hospitalization in one of the departments participating in the study
- At risk of pneumococcal infection according to HCSP recommendations (1)
- Negative pneumococcal vaccination status
- Adult patient (≥18 years old)
Exclusion
- Under safeguard of justice
- Unable to receive informed information
- Patient having objected to the use of their data.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 22 2020
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT04734925
Start Date
March 1 2020
End Date
October 22 2020
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Nimes
Nîmes, France, 30029